Denmark Cancer Immunotherapy Market Size & Outlook
The cancer immunotherapy market in Denmark is expected to reach a projected revenue of US$ 775.4 million by 2033. A compound annual growth rate of 8.8% is expected of Denmark cancer immunotherapy market from 2026 to 2033.
- Pharmaceuticals
- Oncology Drugs
- Cancer Immunotherapy Market Outlook
- Oncology Drugs
Revenue, 2025 (US$M)
$396.1
Estimate, 2026 (US$M)
$429.0
Forecast, 2033 (US$M)
$775.4
CAGR, 2026 - 2033
8.8%
Global Market
Related Markets
Prism AI by Grand View ResearchFree to try
Ask a question about the cancer immunotherapy market
Every figure cited from GVR research
Denmark cancer immunotherapy market highlights
- The Denmark cancer immunotherapy market generated a revenue of USD 396.1 million in 2025 and is expected to reach USD 775.4 million by 2033.
- The Denmark market is expected to grow at a CAGR of 8.8% from 2026 to 2033.
- In terms of segment, monoclonal antibodies was the largest revenue generating product in 2025.
- Oncolytic Viral Therapies and Cancer Vaccines is the most lucrative product segment registering the fastest growth during the forecast period.
Cancer immunotherapy market data book summary
| Market revenue in 2025 | USD 396.1 million |
| Market revenue in 2033 | USD 775.4 million |
| Growth rate | 8.8% (CAGR from 2026 to 2033) |
| Largest segment | Monoclonal antibodies |
| Fastest growing segment | Oncolytic Viral Therapies and Cancer Vaccines |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monoclonal Antibodies, Check Point Inhibitors, Oncolytic Viral Therapies and Cancer Vaccines |
| Key market players worldwide | Pfizer Inc, AstraZeneca PLC, Merck & Co Inc, Roche Holding AG, Bristol-Myers Squibb Co, Novartis AG ADR, Eli Lilly and Co, Johnson & Johnson, Immunocore Holdings PLC ADR |
Other key industry trends
- In terms of revenue, Denmark accounted for 0.3% of the global cancer immunotherapy market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany cancer immunotherapy market is projected to lead the regional market in terms of revenue in 2033.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 8,506.1 million by 2033.
No credit card required*
Publish Date: Dec 03, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Immunotherapy Market Scope
Cancer Immunotherapy Market segmentation & scope
Cancer Immunotherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson | View profile | 134,400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | www.jnj.com |
| Novartis AG ADR | View profile | 76,057 | Lichtstrasse 35, Basel, Switzerland, 4056 | www.novartis.com |
| Pfizer Inc | View profile | 88,000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | www.pfizer.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| Bristol-Myers Squibb Co | View profile | 34,100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | www.bms.com |
| Eli Lilly and Co | View profile | 43,000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | www.lilly.com |
| AstraZeneca PLC | View profile | 89,900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | www.astrazeneca.com |
| Immunocore Holdings PLC ADR | View profile | 497 | 92 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom, OX14 4RY | www.immunocore.com |
Denmark Cancer Immunotherapy Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cancer Immunotherapy Market Outlook will help companies and investors design strategic landscapes.
Monoclonal Antibodies was the largest segment with a revenue share of 64.48% in 2025.
Horizon Databook has segmented the Denmark cancer immunotherapy market based on monoclonal antibodies, check point inhibitors, oncolytic viral therapies and cancer vaccines covering the revenue growth of each sub-segment from 2021 to 2033.
- Denmark Cancer Immunotherapy Market Product Outlook (Revenue, USD Million , 2021-2033)
- Monoclonal Antibodies
- Check Point Inhibitors
- Oncolytic Viral Therapies and Cancer Vaccines
- Denmark Cancer Immunotherapy Market Application Outlook (Revenue, USD Million , 2021-2033)
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head and Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Applications
- Denmark Cancer Immunotherapy Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Denmark Cancer Immunotherapy Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals and Clinics
- Cancer Research Centers
- Other End users
Reasons to subscribe to Cancer Immunotherapy Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Cancer Immunotherapy Market Outlook databook
- Our clientele includes a mix of Cancer Immunotherapy Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark Cancer Immunotherapy Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Denmark Cancer Immunotherapy Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Denmark Cancer Immunotherapy Market, 2021-2033 (US$M)
Denmark cancer immunotherapy market statistics, by product, 2021-2033 (US$M)
